Reporting results of human biomonitoring of environmental chemicals to study participants
A comparison of approaches followed in two Canadian studies
Bibliographic Data
| ID | 11180120 |
|---|---|
| Authors | Douglas A Haines, Douglas Haines (0000-0003-3956-0454, Health Canada, corresponding author), Tye E Arbuckle (Health Canada), Ellen Lye (Health Canada), Melissa Legrand (Health Canada), Mandy Fisher (0000-0003-4656-3813, Health Canada), Renée Langlois (Statistics Canada), William Fraser, William D Fraser (0000-0001-9042-2415, Centre Hospitalier Universitaire Sainte-Justine) |
| Year | 2011 |
| Volume | 65 |
| Issue | 3 |
| Pages | 191-198 |
| Publication date | 2011-03-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Epidemiology and Community Health (JOURNAL) |
| Journal identifiers | ISSN: 0143-005X • E-ISSN: 1470-2738 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/jech.2008.085597 |
| PMID | 20628082 |
| OpenAlex | W2158011729 |
| Language | EN |
| Citations received | 5 |
| References cited | 17 |
Biomonitoring is used increasingly as an indicator and quantitative measure of exposure; however, there is a large gap in interpreting and communicating biomonitoring results to study participants. Two separate, national biomonitoring initiatives are under way in Canada; the household recruitment-based Canadian Health Measures Survey (CHMS) and the clinic recruitment-based Maternal-Infant Research on Environmental Chemicals (MIREC) Study. The CHMS provides participants with the option to receive all their results, but this option is not provided to MIREC participants. The approach to reporting results to participants depends on the availability of reference ranges and guidelines for which tissue concentrations may be interpreted as being elevated or associated with increased health risks, how participants are recruited, unique vulnerabilities of the population, legislation governing access to personal information, and decisions of research ethics committees. It is the researchers' responsibility to present the best case for their approach and, once the decision has been made, to inform participants about access to their results through the consent process
Biomonitoring · Environmental health · Legislation · Population · Climate Change and Health Impacts · Ecology · Effects and risks of endocrine disrupting chemicals · Environmental Justice and Health Disparities · Medicine
Identifying Issues and Priorities in Reporting Back Environmental Health Data
Communicating environmental exposure results and health information in a community-based participatory research study
The Social Significance of Human Biomonitoring
Rethinking the disclosure debates
STrengthening the Reporting of OBservational studies in Epidemiology
| Citations per year | 0.33 |
|---|---|
| Citation span | 2011 - 2020 (10) |
| Highly cited | No |